Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Matinas BioPharma ( (MTNB) ) just unveiled an announcement.
On March 13, 2025, Eric Ende announced his resignation from the Board of Directors and as Chairman of Matinas BioPharma, effective March 14, 2025, due to other professional commitments. His departure was not due to any disagreement or shift in the company’s direction, indicating stability in the company’s strategic focus and operations.
More about Matinas BioPharma
Matinas BioPharma is a company operating in the biopharmaceutical industry, focusing on the development of innovative therapies and products.
YTD Price Performance: -10.51%
Average Trading Volume: 469,999
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $2.72M
See more insights into MTNB stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue